Urological oncology constitutes 20% of all malignant disease, and includes renal, bladder, prostate and testicular cancer. This is an area of medical and scientific interest, where advances in clinical practice and translational research have led to significant changes in the way that patients are managed. The book summarizes developments in all areas of urological cancer including clinical and molecular advances. The aim of the book is to educate...